[1]李图帅,陈 瑾,乔绪稳,等.利用霍乱毒素B亚单位展示猪O型口蹄疫病毒VP1蛋白主要抗原表位[J].江苏农业学报,2016,(03):601.[doi:10.3969/j.issn.1000-4440.2016.03.018]
　LI Tu-shuai,CHEN Jin,et al.Cholera toxin subunit B as carrier for displaying GH loop epitope of type O foot-and-mouth disease virus VP1 protein[J].,2016,(03):601.[doi:10.3969/j.issn.1000-4440.2016.03.018]
点击复制

利用霍乱毒素B亚单位展示猪O型口蹄疫病毒VP1蛋白主要抗原表位()
分享到：

江苏农业学报[ISSN:1006-6977/CN:61-1281/TN]

卷:
期数:
2016年03期
页码:
601
栏目:
畜牧兽医·水产养殖
出版日期:
2016-06-30

文章信息/Info

Title:
Cholera toxin subunit B as carrier for displaying GH loop epitope of type O foot-and-mouth disease virus VP1 protein
作者:
李图帅1; 2;  陈 瑾2;  乔绪稳2;  汪 浩2;  张元鹏2;  侯继波2;  郑其升2;  胡元亮1
1.南京农业大学动物医学院, 江苏 南京 210095; 2. 国家兽用生物制品工程技术研究中心,江苏 南京 210014
Author(s):
LI Tu-shuai1;  2;  CHEN Jin2;  QIAO Xu-wen2;  WANG Hao2;  ZHANG Yuan-peng2;  HOU Ji-bo2;  ZHENG Qi-sheng2;  HU Yuan-liang1
1. College of Veterinary Medicine, Nanjing Agricultural University, Nanjing 210095, China; 2. National Research Center of Veterinary Biological Engineering and Technology, Nanjing 210014, China
关键词:
重组霍乱毒素B亚单位;  猪O型口蹄疫病毒;  GHloop抗原表位;  亚单位疫苗
Keywords:
cholera toxin B;  type O foot-and-disease virus;  GHloop;  subunit vaccine
分类号:
S859.79+7
DOI:
10.3969/j.issn.1000-4440.2016.03.018
文献标志码:
A
摘要:
为探讨以霍乱毒素B亚单位为载体制备口蹄疫亚单位疫苗的可行性,利用E. coli表达CTB-GHloop嵌合基因,用 SDS-PAGE分析目的基因的表达及表达产物的可溶性,利用神经节苷脂(GM1)为抗原鉴定重组蛋白五聚体的形成。将目的蛋白浓度调整为200 μg/ml,以白油佐剂乳化制备疫苗,免疫健康仔猪,免疫后利用ELISA测定特异性抗体水平,评价免疫后体液免疫反应,利用淋巴细胞增殖实验评价细胞免疫水平。结果表明嵌合基因在E. coli中获得高效表达,重组蛋白可溶,并能够形成五聚体; Western-blot结果显示重组蛋白能够与口蹄疫病毒(FMDV)阳性血清发生反应; 以每头仔猪200 μg免疫,试验猪产生较高的抗体水平与细胞免疫反应。
Abstract:
The object of this study is to find out whether cholera toxin subunit B(CTB)is suitable for displaying GH loop epitope of type O FMDV(foot-and-mouth disease virus). The chimeric gene CTB-GHloop was expressed in Escherichia coli. SDS-PAGE was used to detect the expression and the solubility of the recombinant protein. Ganglioside M1 coated plate was involved as antigen to identify antibody by ELISA. The immunogenicity of chimeric CTB-GHloop protein was evaluated on pigs by detection of FMDV specific antibody and lymphocyte proliferation activity against GHloop epitope. Recombinant protein was identified in the form of pentamers by Wester-blot. Antibody test results revealed that piglet immunized with 200 μg recombinant CTB-GHloop protein developed not only higher titer of antibodies in a short period of time, but also more vigorous T cell immune response compared with the commercial vaccines. It is concluded that CTB protein could be used as a carrier to display other antigenic epitope with no influence on the formation of pentamers, and the recombinant protein CTB-GHloop may be a promising candidate for FMDV subunit vaccine research.

参考文献/References:

[1] 解慧梅, 穆 祥,刘易通,等.口蹄疫的研究现状 [J]. 动物医学进展,2006(5): 6-9.
[2] 韦显凯,郑 敏,郑列丰,等. 规模猪场不同免疫次数对口蹄疫抗体产生效果的影响[J].南方农业学报, 2014,45(3):494-497.
[3] 覃 军,梁珠民,李军成. 规模化猪场主要疫病抗体监测与免疫效果分析[J]. 江苏农业科学,2015,43(10): 264-266.
[4] HAYDON D T, KAO R R, KITCHING R P. The UK foot-and-mouth disease outbreak—the after math [J]. Nature Review: Microbiology, 2004, 2:674-681.
[5] ERIC BARANOWSKI E D, CRISTINA E F S. Foot-and-mouth disease virus [J]. Microbiology & Infectious Diseases, 2002, 25: 297-308.
[6] 张晓凤. 口蹄疫病毒的基因分型 [J]. 畜牧与饲料科学,2006(2):30-32.
[7] 刘庆军, 张永光. 口蹄疫病毒基因组结构及其功能 [J].动物医学进展,2005,26(5):1-5.
[8] HUANG C C, LIN Y L, HUANG T S. Nolecular characterization of foot-and-mouth disease virus isolated from ruminants in Taiwan in 1999-2000 [J]. Vet Microbiol, 2001, 81(6):193-205.
[9] WANG J H, LIANG C M, PENG J M, et al. Induction of immunity in swine by purified recombinant VP1 of foot-and-mouth disease virus [J]. Vaccine, 2003,21:3721-3729.
[10] 胡 波,盛 蓉,宋艳华,等. RHDV VLPs 对口蹄疫病毒B 细胞表位的展示效果[J]. 江苏农业学报, 2015, 31(6): 1362-1370.
[11] AGGARWAL N, BARNETT P V. Antigenic sites of foot-and-mouth disease virus(FMDV): an analysis of the specificities of anti-FMDV antibodies after vaccination of naturally susceptible host species [J]. J Gen Virol, 2002(2):775-782.
[12] PARRY N R, BARNETT P V, OULDRIDGE E J, et al. Neutralizing epitopes of type O foot-and-mouth disease virus. II. Mapping three conformational sites with synthetic peptide reagents [J]. J Gen Virol,1989, 70(6):1493-1503.
[13] BITTLE J L, HOUGHTEN R A, ALEXANDER H, et al. Protection against foot-and-mouth disease by immunization with a chemically synthesized peptide predicted from the viral nucleotide sequence [J]. Nature, 1982, 298: 30-33.
[14] WANG C Y, CHANG T Y, Walfield A M, et al. Synthetic peptide-based vaccine and diagnostic system for effective control of FMD [J]. Biologicals, 2001,29(8): 221-228.
[15] WANG C Y, CHANG T Y, WALFIELD A M, et al. Effective synthetic peptide vaccine for foot-and-mouth disease in swine [J]. Vaccine, 2002, 20(6): 2603-2610.
[16] MEKALANOS J J, SWARTZ D J, Pearson G D, et al. Cholera toxin genes: nucleotide sequence, deletion analysis and vaccine development [J]. Nature, 1983,306(5943):551-557.
[17] SPAGLER B D. Structure and function of cholera toxin and the related Escherichia coli heat-labile enterotoxin[J]. Microbiol Rev, 1992, 56(9):622-647.
[18] HARAKUNI T, SUGAWA H, KOMESU A, et al. Heteropentameric cholera toxin B subunit chimeric molecules genetically fused to a vaccine antigen induces systemic and mucosal immune responses: a potential new strategy to target recombinant vaccine antigens to mucosal immune systems [J]. Infect Immun, 2005, 73(9):5654-5665.
[19] PIZZA M, GIULIANI M, FONTANA M, et al. Mucosal vaccines: nontoxic derivatives of LT and CT as mucosal adjuvants [J]. Vaccine, 2001, 19(17-19): 2534-2541.
[20] SUN J B, RAGHAVAN S, SJ?LING A, et al. Oral tolerance induction with antigen conjugated to cholera toxin B subunit generates both Foxp3+ CD25+ and Foxp3- CD25- CD4+ regulatory T cells[J]. J Immunol, 2006, 177(11): 7634-7644.
[21] MAXIM T, JIANG X Q, KONG X P, et al. Structure-guided design and immunological characterization of immunogens presenting the HIV-1 gp120 V3 loop on a CTB scaffold [J]. Virology, 2010, 405(12):513-523.
[22] LUCI C, HERVOUET C, ROUSSEAU D, et al. Dendritic cell-mediated induction of mucosal cytotoxic responses following intravaginal immunization with the nontoxic B subunit of cholera toxin[J]. J Immunol, 2006, 176(5): 2749-2757.
[23] TABOGA O, TAMI C, CARRILLO E, et al. A large-scale evaluation of peptide vaccines against foot-and-mouth disease: lack of solid protection in cattle and isolation of escape mutants [J]. J Virol, 1997, 71(4):2606-2614.
[24] KUPRIIANOVA M A, ZHMAKM N, KOROEV D O, et al. Synthetic peptide designs based on immunoactive fragments of the VP1 protein of the foot-and-mouth disease virus strain A22 [J]. Bioorg Khim, 2000, 26(12): 926-932.

备注/Memo

备注/Memo:
收稿日期:2015-11-20
基金项目:江苏省农业科技自主创新专项[CX(14)2089]
作者简介::李图帅(1989-),男,山东兖州人,硕士研究生,主要从事猪用新型疫苗及技术研究
通讯作者:郑其升,(E-mail)njcvc1302@163.com;(Tel)025-84392078。胡元亮,(E-mail)ylhu @sohu.com
更新日期/Last Update: 2016-06-30